Tryptase and protease-activated receptor-2 stimulate scratching behavior in a murine model of ovalbumin-induced atopic-like dermatitis

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 507-512

  Zhu, Yu ^a,b   Pan, Wei Hua ^a,b   Wang, Xiao Rong ^f   Liu, Ying ^g   Chen, Min ^a,b,c,d   Xu, Xiao Guang ^b,c,d   Liao, Wan Qing ^b,c,d   Hu, Jin Hong ^e  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Institute of Medical Mycology   (China)

^c Shanghai Key Laboratory of Molecular Andrology   (China)

^d PLA Key Laboratory of Mycosis   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f HEILONGJIANG PROVINCIAL HOSPITAL   (China)

^g Tongji Vocational College of Science and Technology   (China)

Author keywords

Atopic dermatitis; Mast cell; Protease activated receptor 2; Pruritus; Tacrolimus

Indexed keywords

CETIRIZINE; MESSENGER RNA; OVALBUMIN; PROTEINASE ACTIVATED RECEPTOR 2; TACROLIMUS; TRYPTASE; ALLERGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; DISEASE ASSOCIATION; ENZYME INDUCTION; FEMALE; MAST CELL DEGRANULATION; MOUSE; MURINE MODEL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; SCRATCHING; SKIN PRURITUS; ANIMAL; ANIMAL BEHAVIOR; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PRURITUS; SKIN;

ALLERGENS; ANIMALS; BEHAVIOR, ANIMAL; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; FEMALE; MICE, INBRED BALB C; OVALBUMIN; PRURITUS; RECEPTOR, PAR-2; RNA, MESSENGER; SKIN; TRYPTASES;

EID: 84937833409     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.04.047     Document Type: Article

References (41)

1. D.Y. Leung, and T. Bieber Atopic dermatitis Lancet 361 2003 151 160
2. S. Ständer, E. Weisshaar, and T.A. Luger Neurophysiological and neurochemical basis of modern pruritus treatment Exp. Dermatol. 17 2008 161 169
3. Y. Zhu, X.R. Wang, C. Peng, J.G. Xu, Y.X. Liu, L. Wu, and et al. Induction of leukotriene B(4) and prostaglandin E(2) release from keratinocytes by protease-activated receptor-2-activating peptide in ICR mice Int. Immunopharmacol. 9 2009 1332 1336
4. R.F. Carvalho, G. Nilsson, and I.T. Harvima Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation Exp. Dermatol. 19 2010 117 122
5. M. Steinhoff, N. Vergnolle, S.H. Young, M. Tognetto, S. Amadesi, H.S. Ennes, and et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism Nat. Med. 6 2000 151 158
6. V. Shpacovitch, M. Feld, N.W. Bunnett, and M. Steinhoff Protease-activated receptors: novel PARtners in innate immunity Trends Immunol. 28 2007 541 550
7. M. Steinhoff, J. Bienenstock, M. Schmelz, M. Maurer, E. Wei, and T. Bíró Neurophysiological, neuroimmunological and neuroendocrine basis of pruritus J. Invest. Dermatol. 126 2006 1705 1718
8. S.G. Shimada, K.A. Shimada, and J.G. Collins Scratching behavior in mice induced by the proteinase-activated receptor-2 agonist, SLIGRL-NH2 Eur. J. Pharmacol. 530 2006 281 283
9. J.M. Spergel, E. Mizoguchi, J.P. Brewer, T.R. Martin, A.K. Bhan, and R.S. Geha Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice J. Clin. Invest. 101 1998 1614 1622
10. J.M. Spergel, E. Mizoguchi, H. Oettgen, A.K. Bhan, and R.S. Geha Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis J. Clin. Invest. 103 1999 1103 1111
11. R. Yatsuzuka, T. Inoue, S. Jiang, Y. Nakano, and C. Kamei Development of new atopic dermatitis models characterized by not only itching but also inflammatory skin in mice Eur. J. Pharmacol. 565 2007 225 231
12. S. Reitamo, J. Harper, J.D. Bos, F. Cambazard, C. Bruijnzeel-Koomen, P. Valk, and et al. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial Br. J. Dermatol. 150 2004 554 562
13. Y. Kuraishi, T. Nagasawa, K. Hayashi, and M. Satoh Scratching behavior induced by pruritogenic but not algesiogenic agents in mice Eur. J. Pharmacol. 275 1995 229 233
14. N. Cenac, A.M. Coelho, C. Nguyen, S. Compton, P. Andrade-Gordon, W.K. MacNaughton, and et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2 Am. J. Pathol. 161 2002 1903 1915
15. C.S. Mullan, M. Riley, D. Clarke, A. Tatler, A. Sutcliffe, A.J. Knox, and et al. Beta-tryptase regulates IL-8 expression in airway smooth muscle cells by a PAR-2-independent mechanism Am. J. Respir. Cell Mol. Biol. 38 2008 600 608
16. L.B. Schwartz, A.M. Irani, K. Roller, M.C. Castells, and N.M. Schechter Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells J. Immunol. 138 1987 2611 2615
17. D.D. Metcalfe, D. Baram, and Y.A. Mekori Mast cells Physiol. Rev. 77 1997 1033 1079
18. J.K. Bell, D.S. McQueen, and J.L. Rees Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice Br. J. Pharmacol. 142 2004 374 380
19. N. Inagaki, T. Sakurai, T. Abe, K. Musoh, H. Kawasaki, M. Tsunematsu, and et al. Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice Life Sci. 63 1998 PL145 PL150
20. Y. Zhu, C. Peng, J.G. Xu, Y.X. Liu, Q.G. Zhu, J.Y. Liu, and et al. Participation of proteinase-activated receptor-2 in passive cutaneous anaphylaxis-induced scratching behavior and the inhibitory effect of tacrolimus Biol. Pharm. Bull. 32 2009 1173 1176
21. C. Moormann, M. Artuc, E. Pohl, G. Varga, J. Buddenkotte, N. Vergnolle, and et al. Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells J. Invest. Dermatol. 126 2006 746 755
22. M. Steinhoff, C.U. Corvera, M.S. Thoma, W. Kong, B.E. McAlpine, G.H. Caughey, and et al. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase Exp. Dermatol. 8 1999 282 294
23. K. Tsujii, T. Andoh, H. Ui, J.B. Lee, and Y. Kuraishi Involvement of tryptase and proteinase-activated receptor-2 in spontaneous itch-associated response in mice with atopy-like dermatitis J. Pharmacol. Sci. 109 2009 388 395
24. T. Sasagawa, Y. Higashi, S. Sakuma, Y. Hirayama, Y. Sasagawa, Y. Ohkubo, and et al. Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC/Nga mice Int. Arch. Allergy Immunol. 126 2001 239 247
25. S. Davidson, and G.J. Giesler The multiple pathways for itch and their interactions with pain Trends Neurosci. 33 2010 550 558
26. R. Tarroux, M.F. Assalit, D. Licu, J.J. Périé, and D. Redoulès Variability of enzyme markers during clinical regression of atopic dermatitis Skin Pharmacol. Appl. Ski. Physiol. 15 2002 55 62
27. N. Komatsu, K. Saijoh, C. Kuk, A.C. Liu, S. Khan, F. Shirasaki, and et al. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients Exp. Dermatol. 16 2007 513 519
28. S.E. Lee, S.K. Jeong, and S.H. Lee Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis Yonsei Med. J. 51 2010 808 822
29. M.J. Cork, S.G. Danby, Y. Vasilopoulos, J. Hadgraft, M.E. Lane, M. Moustafa, and et al. Epidermal barrier dysfunction in atopic dermatitis J. Invest. Dermatol. 129 2009 1892 1908
30. G. Yosipovitch, M.W. Greaves, and M. Schmelz Itch Lancet 361 2003 690 694
31. H. Ui, T. Andoh, J.B. Lee, H. Nojima, and Y. Kuraishi Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice Eur. J. Pharmacol. 530 2006 172 178
32. L. Hou, S. Kapas, A.T. Cruchley, M.G. Macey, P. Harriott, C. Chinni, and et al. Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro Immunology 94 1998 356 362
33. K. Stefansson, M. Brattsand, D. Roosterman, C. Kempkes, G. Bocheva, M. Steinhoff, and et al. Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases J. Invest. Dermatol. 128 2008 18 25
34. S.K. Jeong, H.J. Kim, J.K. Youm, S.K. Ahn, E.H. Choi, M.H. Sohn, and et al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery J. Invest. Dermatol. 128 2008 1930 1939
35. S. Kitano, K. Irimura, T. Sasaki, N. Abe, A. Baba, Y. Miyake, and et al. Suppression of gingival inflammation induced by porphyromonas gingivalis in rats by leupeptin Jpn. J. Pharmacol. 85 2001 84 91
36. T. Aoyagi, S. Miyata, M. Nanbo, F. Kojima, and M. Matsuzaki Biological activities of leupeptins J. Antibiot. 22 1969 558 568
37. P. Goettig, V. Magdolen, and H. Brandstetter Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs) Biochimie 92 2010 1546 1567
38. S. Takeuchi, H. Saeki, S. Tokunaga, M. Sugaya, H. Ohmatsu, Y. Tsunemi, and et al. A randomized, open-label, multicenter trial of topical tacrolimus for the treatment of pruritis in patients with atopic dermatitis Ann. Dermatol. 24 2012 144 150
39. T. Sengoku, S. Kishi, S. Sakuma, Y. Ohkubo, and T. Goto FK506 inhibition of histamine release and cytokine production by mast cells and basophils Int. J. Immunopharmacol. 22 2000 189 201
40. T. Zuberbier, S.U. Chong, K. Grunow, S. Guhl, P. Welker, M. Grassberger, and et al. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils J. Allergy Clin. Immunol. 108 2001 275 280
41. T. Nakano, T. Andoh, M. Tayama, M. Kosaka, J.B. Lee, and Y. Kuraishi Effects of topical application of tacrolimus on acute itch-associated responses in mice Biol. Pharm. Bull. 31 2008 752 754